Jenny Byrne

5.8k total citations
124 papers, 3.1k citations indexed

About

Jenny Byrne is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Jenny Byrne has authored 124 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Hematology, 34 papers in Genetics and 32 papers in Oncology. Recurrent topics in Jenny Byrne's work include Hematopoietic Stem Cell Transplantation (45 papers), Acute Myeloid Leukemia Research (29 papers) and Acute Lymphoblastic Leukemia research (28 papers). Jenny Byrne is often cited by papers focused on Hematopoietic Stem Cell Transplantation (45 papers), Acute Myeloid Leukemia Research (29 papers) and Acute Lymphoblastic Leukemia research (28 papers). Jenny Byrne collaborates with scholars based in United Kingdom, United States and France. Jenny Byrne's co-authors include Nigel H. Russell, Gordon Cook, Gareth J. Morgan, Sue Bell, Roger G. Owen, J. Anthony Child, Walter M. Gregory, Graham Jackson, Huw Roddie and Faith E. Davies and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Jenny Byrne

114 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jenny Byrne United Kingdom	29	2.2k	1.0k	853	586	416	124	3.1k
Andrzej Hellmann Poland	24	2.0k 0.9×	1.1k 1.1×	834 1.0×	1.1k 1.9×	940 2.3×	130	4.0k
T. de Witte Netherlands	36	3.1k 1.4×	843 0.8×	918 1.1×	708 1.2×	788 1.9×	112	4.2k
Anthony P. Schwarer Australia	29	2.1k 1.0×	591 0.6×	1.1k 1.3×	378 0.6×	886 2.1×	119	3.3k
Hee‐Je Kim South Korea	26	2.0k 0.9×	736 0.7×	464 0.5×	605 1.0×	717 1.7×	271	3.0k
Andreas Hirt Switzerland	26	1.3k 0.6×	598 0.6×	430 0.5×	312 0.5×	856 2.1×	89	3.1k
Denis Guyotat France	31	1.9k 0.9×	1.0k 1.0×	459 0.5×	956 1.6×	553 1.3×	124	3.4k
Yves Chalandon Switzerland	34	2.3k 1.0×	995 1.0×	553 0.6×	494 0.8×	761 1.8×	192	4.3k
Gerald J. Elfenbein United States	29	1.5k 0.7×	1.0k 1.0×	356 0.4×	482 0.8×	696 1.7×	97	3.2k
Giuseppe Milone Italy	31	2.2k 1.0×	851 0.8×	366 0.4×	1.2k 2.0×	466 1.1×	142	3.2k
Agnès Devergie France	28	2.1k 1.0×	627 0.6×	485 0.6×	277 0.5×	800 1.9×	55	3.0k

Countries citing papers authored by Jenny Byrne

Since Specialization

Citations

This map shows the geographic impact of Jenny Byrne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Byrne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Byrne more than expected).

Fields of papers citing papers by Jenny Byrne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny Byrne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Byrne. The network helps show where Jenny Byrne may publish in the future.

Co-authorship network of co-authors of Jenny Byrne

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny Byrne. A scholar is included among the top collaborators of Jenny Byrne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny Byrne. Jenny Byrne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sedehizadeh, Saam, et al.. (2025). Expanding the clinical spectrum of NHP2-related dyskeratosis congenita: a case with novel phenotypic features. Clinical Dysmorphology. 34(3). 83–87.

Robertson, H, Dragana Milojković, Nauman M. Butt, et al.. (2024). Expectations and outcomes of varying treatment strategies for CML presenting during pregnancy. British Journal of Haematology. 205(3). 947–955. 6 indexed citations

Baron, Frédéric, Myriam Labopin, Jurjen Versluis, et al.. (2024). Higher survival following transplantation with a mismatched unrelated donor with posttransplant cyclophosphamide‐based graft‐versus‐host disease prophylaxis than with double unit umbilical cord blood in patients with acute myeloid leukemia in first complete remission: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. American Journal of Hematology. 99(12). 2296–2305.

Nagler, Arnon, Myriam Labopin, Stephan Mielke, et al.. (2023). Matched related versus unrelated versus haploidentical donors for allogeneic transplantation in AML patients achieving first complete remission after two induction courses: a study from the ALWP/EBMT. Bone Marrow Transplantation. 58(7). 791–800. 7 indexed citations

Dignan, Fiona L., Angela Hamblin, Jungwha Lee, et al.. (2020). Survivorship care for allogeneic transplant patients in the UK NHS: changes centre practice, impact of health service policy and JACIE accreditation over 5 years. Bone Marrow Transplantation. 56(3). 673–678. 7 indexed citations

Saraceni, Francesco, Myriam Labopin, Édouard Forcade, et al.. (2020). Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT). Cancer Medicine. 10(1). 23–33. 9 indexed citations

Perić, Zinaida, Myriam Labopin, Christophe Peczynski, et al.. (2020). Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation—a retrospective study by the Acute Leukemia Working Party of EBMT. Bone Marrow Transplantation. 55(8). 1560–1569. 13 indexed citations

Gilleece, Maria, Myriam Labopin, Bipin N. Savani, et al.. (2019). Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT. Leukemia. 34(1). 87–99. 24 indexed citations

O’Brien, Stephen J., Letizia Foroni, Wendy Osborne, et al.. (2018). Spirit 2: Final 5 Year Analysis of the UK National Cancer Research Institute Randomized Study Comparing Imatinib with Dasatinib in Patients with Newly Diagnosed Chronic Phase CML. Blood. 132(Supplement 1). 457–457. 10 indexed citations

10.

Shaw, Bronwen E., Jane F. Apperley, Nigel H. Russell, et al.. (2011). Unrelated donor peripheral blood stem cell transplants incorporating pre‐transplant in‐vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graft‐versus‐host disease. British Journal of Haematology. 153(2). 244–252. 14 indexed citations

11.

Shaw, Bronwen E., Jane F. Apperley, Nigel H. Russell, et al.. (2010). A comparison of stem cell source in adult and paediatric recipients of T-cell depleted myeloablative transplants for standard risk leukaemia: no difference in mortality using BM or PBSC. 1. 1 indexed citations

12.

Shaw, Bronwen E., et al.. (2007). Clinical impact of MRSA in a stem cell transplant unit: analysis before, during and after an MRSA outbreak. Bone Marrow Transplantation. 39(10). 623–629. 22 indexed citations

13.

Sirohi, Bhawna, R Powles, Rajesh Chopra, et al.. (2006). A study to determine the safety profile and maximum tolerated dose of micafungin (FK463) in patients undergoing haematopoietic stem cell transplantation. Bone Marrow Transplantation. 38(1). 47–51. 68 indexed citations

14.

Fern, Lorna A., et al.. (2004). Clonal haemopoiesis may occur after conventional chemotherapy and is associated with accelerated telomere shortening and defects in the NQO1 pathway; possible mechanisms leading to an increased risk of t‐AML/MDS. British Journal of Haematology. 126(1). 63–71. 33 indexed citations

15.

Parker, Jane E., Tariq Shafi, Antonio Pagliuca, et al.. (2002). Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced‐intensity conditioning compared with standard preparative regimens. British Journal of Haematology. 119(1). 144–154. 66 indexed citations

16.

Feng, Liang, Mark W. Drummond, Jenny Byrne, et al.. (2002). Molecular monitoring of complete cytogenetic responders following treatment with imatinib (STI571, Gleevec) for CML: A report from the UKSTI571 study group.. Blood. 100(11). 1425. 7 indexed citations

17.

Russell, NH, Gavin Cull, Jenny Byrne, et al.. (1999). Evaluation of non-myeloablative conditioning combining beam with in vivo pre-transplant Campath-IG for allogeneic transplantation in patients with lymphoma.. Blood. 94. 5 indexed citations

18.

Byrne, Jenny, et al.. (1998). THE MOLECULAR PATHOPHYSIOLOGY OF MYELOID LEUKAEMIAS: Ras REVISITED. British Journal of Haematology. 100(2). 256–264. 35 indexed citations

19.

Cassidy, Michael, et al.. (1998). Heparin-induced thrombocytopenia (HIT) and thrombosis syndrome in a haemodialysis-dependent patient with systemic vasculitis. Nephrology Dialysis Transplantation. 13(12). 3226–3229. 13 indexed citations

20.

Byrne, Jenny, et al.. (1969). Laboratory studies on the rimino-phenazines.. PubMed. 50. Suppl:22–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact